Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tango Therapeutics Inc (TNGX)

Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tango Therapeutics Inc 201 BROOKLINE AVE. SUITE 901 BOSTON MA 02215 USA

www.tangotx.com Employees: 137 P: 857-320-4900

Sector:

Medical

Description:

Tango Therapeutics Inc. is a biotechnology company. It focused on discovering and delivering precision cancer medicines. Tango Therapeutics Inc., formerly known as BCTG Acquisition Corp., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 2,979,346
Enterprise Value, $K 2,866,636
Shares Outstanding, K 142,689
Float, K 131,987
% Float 92.50%
Short Interest, K 48,739
Short Float 34.16%
Days to Cover 18.20
Short Volume Ratio 0.45
% of Insider Shareholders 7.50%
% of Institutional Shareholders 78.99%

Financials:

Annual Sales, $ 62,380 K
Annual Net Income, $ -101,590 K
Last Quarter Sales, $ 53,810 K
Last Quarter Net Income, $ 15,880 K
EBIT, $ -110,340 K
EBITDA, $ -110,750 K

Growth:

1-Year Return 1,189.61%
3-Year Return 402.78%
5-Year Return 80.87%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 03/05/26
Next Earnings Date 05/11/26
Earnings Per Share ttm -0.93
EPS Growth vs. Prev Qtr -323.08%
EPS Growth vs. Prev Year 17.14%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TNGX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -50.30%
Return-on-Assets % -36.25%
Profit Margin % -162.86%
Debt/Equity 0.00
Price/Sales 44.56
Price/Cash Flow N/A
Price/Book 7.58
Book Value/Share 1.19
Interest Coverage -1.45
60-Month Beta 1.76
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.